各种示踪技术在乳腺癌前哨淋巴结的应用进展
Application Progress of Various Tracer Techniques in Sentinel Lymph Node of Breast Cancer
DOI: 10.12677/acm.2024.1472090, PDF,  被引量    科研立项经费支持
作者: 牛向阳*：济宁医学院临床医学院，山东 济宁；冯其贞#, 熊 斌#：济宁医学院附属医院乳腺外科，山东 济宁
关键词: 乳腺癌；示踪方法；前哨淋巴结；Breast Cancer； Tracing Method； Sentinel Lymph Node
摘要: 乳腺癌是全球范围内最常见的癌症，且发病率逐年上升，非常严重影响女性身体和身心健康。而前哨淋巴结(sentinel lymph node, SLN)为乳腺癌淋巴结转移的第一个或第一组淋巴结，可反映腋窝淋巴结的病理状态，是影响患者预后的重要因素。目前，前哨淋巴结活检(sentinel lymph node biopsy, SLNB)已成为临床淋巴结阴性乳腺癌患者腋窝分期的标准，随着示踪技术的进步，各种示踪技术在乳腺癌前哨淋巴结检查中得到广泛应用，可提高检查准确率。本文对各种示踪技术在乳腺癌前哨淋巴结检查中的应用进行综述。
Abstract: Breast cancer is the most common cancer in the world, and its incidence is increasing year by year, which seriously affects women’s physical and mental health. Sentinel lymph node (SLN) is the first or first group of lymph node metastasis in breast cancer, which can reflect the pathological state of axillary lymph nodes and is an important factor affecting the prognosis of patients. At present, sentinel lymph node biopsy (SLNB) has become the standard of axillary staging in patients with clinical lymph node-negative breast cancer. With the progress of tracer technology, various tracer techniques have been widely used in sentinel lymph node examination of breast cancer, which can improve the accuracy of examination. This article reviews the application of various tracer techniques in sentinel lymph node examination of breast cancer.
文章引用：牛向阳, 冯其贞, 熊斌. 各种示踪技术在乳腺癌前哨淋巴结的应用进展[J]. 临床医学进展, 2024, 14(7): 870-876. https://doi.org/10.12677/acm.2024.1472090

参考文献

[1] Sung, H., Ferlay, J., Siegel, R.L., Laversanne, M., Soerjomataram, I., Jemal, A., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
[2] Gradishar, W.J., Anderson, B.O., Abraham, J., Aft, R., Agnese, D., Allison, K.H., et al. (2020) Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network, 18, 452-478. [Google Scholar] [CrossRef] [PubMed]
[3] Kim, B.K., Park, B., Hur, M.H., Lee, H., Park, M.H., Jeong, J., et al. (2020) Omission of Axillary Lymph Node Dissection in Patients Who Underwent Total Mastectomy with 1 or 2 Metastatic Lymph Nodes. Annals of Surgical Treatment and Research, 98, 283-290. [Google Scholar] [CrossRef] [PubMed]
[4] Garcia-Etienne, C.A., Mansel, R.E., Tomatis, M., Heil, J., Biganzoli, L., Ferrari, A., et al. (2019) Trends in Axillary Lymph Node Dissection for Early-Stage Breast Cancer in Europe: Impact of Evidence on Practice. The Breast, 45, 89-96. [Google Scholar] [CrossRef] [PubMed]
[5] Leong, S.P., Pissas, A., Scarato, M., Gallon, F., Pissas, M.H., Amore, M., et al. (2021) The Lymphatic System and Sentinel Lymph Nodes: Conduit for Cancer Metastasis. Clinical & Experimental Metastasis, 39, 139-157. [Google Scholar] [CrossRef] [PubMed]
[6] Cserni, G., Maguire, A., Bianchi, S., Ryska, A. and Kovács, A. (2021) Sentinel Lymph Node Assessment in Breast Cancer—An Update on Current Recommendations. Virchows Archiv, 480, 95-107. [Google Scholar] [CrossRef] [PubMed]
[7] Lyman, G.H., Temin, S., Edge, S.B., Newman, L.A., Turner, R.R., Weaver, D.L., et al. (2014) Sentinel Lymph Node Biopsy for Patients with Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update. Journal of Clinical Oncology, 32, 1365-1383. [Google Scholar] [CrossRef] [PubMed]
[8] Frountzas, M., Theodoropoulos, C., Karathanasis, P., Nikolaou, C., Zografos, C.G., Larentzakis, A., et al. (2021) Severe Anaphylactic Reaction after Blue Dye Injection for Sentinel Lymph Node Biopsy in Breast Surgery: Report of Two Cases and Literature Review. Clinical Case Reports, 9, 1-5. [Google Scholar] [CrossRef] [PubMed]
[9] Thevarajah, S., Huston, T.L. and Simmons, R.M. (2005) A Comparison of the Adverse Reactions Associated with Isosulfan Blue versus Methylene Blue Dye in Sentinel Lymph Node Biopsy for Breast Cancer. The American Journal of Surgery, 189, 236-239. [Google Scholar] [CrossRef] [PubMed]
[10] Zhang, J., Wang, T., Yan, C., Huang, M., Fan, Z. and Ling, R. (2020) clinical Practice Status of Sentinel Lymph Node Biopsy for Early-Stage Breast Cancer Patients in China: A Multicenter Study. Clinical Epidemiology, 12, 917-924. [Google Scholar] [CrossRef] [PubMed]
[11] Yang, B., Ren, G., Song, E., Pan, D., Zhang, J., Wang, Y., et al. (2020) Current Status and Factors Influencing Surgical Options for Breast Cancer in China: A Nationwide Cross-Sectional Survey of 110 Hospitals. The Oncologist, 25, e1473-e1480. [Google Scholar] [CrossRef] [PubMed]
[12] Lin, J., Lin, L., Chen, D., Lin, K., Wang, Y. and Chang, Y. (2020) Indocyanine Green Fluorescence Method for Sentinel Lymph Node Biopsy in Breast Cancer. Asian Journal of Surgery, 43, 1149-1153. [Google Scholar] [CrossRef] [PubMed]
[13] Vidal-Sicart, S., Rioja, M.E., Prieto, A., Goñi, E., Gómez, I., Albala, M.D., et al. (2020) Sentinel Lymph Node Biopsy in Breast Cancer with 99mTc-Tilmanocept: A Multicenter Study on Real-Life Use of a Novel Tracer. Journal of Nuclear Medicine, 62, 620-627. [Google Scholar] [CrossRef] [PubMed]
[14] Goyal, A., Newcombe, R.G., Chhabra, A. and Mansel, R.E. (2006) Factors Affecting Failed Localisation and False-Negative Rates of Sentinel Node Biopsy in Breast Cancer—Results of the ALMANAC Validation Phase. Breast Cancer Research and Treatment, 99, 203-208. [Google Scholar] [CrossRef] [PubMed]
[15] 孙晓, 陈玉光, 邱鹏飞, 等. 乳腺癌前哨淋巴结活检术的示踪剂[J]. 中国临床药理学杂志, 2022, 38(4): 347-351.
[16] Ye, J., Guo, B., Liu, Q., Ma, F., Liu, H., Wu, Q., et al. (2021) Clinical Practice Guidelines for Sentinel Lymph Node Biopsy in Patients with Early-Stage Breast Cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2021. Chinese Medical Journal, 134, 886-894. [Google Scholar] [CrossRef] [PubMed]
[17] National Institute for Health and Care Excellence (NICE) (2023) Early and Locally Advanced Breast Cancer: Diagnosis and Management.
[18] Long, Y., Xiaowei, Q., Yi, Z., Xinhua, Y., Fan, Z., Linjun, F., et al. (2018) Comparison of Sentinel Lymph Node Detection Performances Using Blue Dye in Conjunction with Indocyanine Green or Radioisotope in Breast Cancer Patients: A Prospective Single-Center Randomized Study. Cancer Biology & Medicine, 15, 452-460. [Google Scholar] [CrossRef] [PubMed]
[19] Yang, J., Xu, L., Liu, P., Du, Z., Chen, J., Liang, F., et al. (2020) Accuracy of Sentinel Lymph Node Biopsy in Breast Cancer: Pitfalls in the Application of Single Tracers. Cancer Management and Research, 12, 3045-3051. [Google Scholar] [CrossRef] [PubMed]
[20] Cui, Q., Dai, L., Li, J. and Xue, J. (2020) Accuracy of CEUS-Guided Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: A Study Review and Meta-Analysis. World Journal of Surgical Oncology, 18, Article No. 112. [Google Scholar] [CrossRef] [PubMed]
[21] 陈诚, 谷成, 任茜, 等. 前哨淋巴结活检对比纳米碳在腋窝前哨淋巴结活检中的准确性分析[J]. 名医, 2020(4): 102.
[22] 徐彦博, 苏杭, 陈梓桐, 等. 纳米碳与亚甲蓝在乳腺癌前哨淋巴结活检中的应用效果比较(Meta分析) [J]. 医疗装备, 2023, 36(15): 154-160.
[23] 中国抗癌协会乳腺癌专业委员会. 中国抗癌协会乳腺癌诊治指南与规范(2021年版) [J]. 中国癌症杂志, 2021, 31(10): 954-1040.
[24] Alander, J.T., Kaartinen, I., Laakso, A., Pätilä, T., Spillmann, T., Tuchin, V.V., et al. (2012) A Review of Indocyanine Green Fluorescent Imaging in Surgery. International Journal of Biomedical Imaging, 2012, Article ID: 940585. [Google Scholar] [CrossRef] [PubMed]
[25] Akrida, I., Michalopoulos, N.V., Lagadinou, M., Papadoliopoulou, M., Maroulis, I. and Mulita, F. (2023) An Updated Review on the Emerging Role of Indocyanine Green (ICG) as a Sentinel Lymph Node Tracer in Breast Cancer. Cancers, 15, Article 5755. [Google Scholar] [CrossRef] [PubMed]
[26] Wang, Z., Yang, X., Wang, J., Liu, P., Pan, Y., Han, C., et al. (2021) Real-Time in Situ Navigation System with Indocyanine Green Fluorescence for Sentinel Lymph Node Biopsy in Patients with Breast Cancer. Frontiers in Oncology, 11, Article 621914. [Google Scholar] [CrossRef] [PubMed]
[27] Bargon, C.A., Huibers, A., Young-Afat, D.A., Jansen, B.A.M., Borel-Rinkes, I.H.M., Lavalaye, J., et al. (2022) Sentinel Lymph Node Mapping in Breast Cancer Patients through Fluorescent Imaging Using Indocyanine Green. Annals of Surgery, 276, 913-920. [Google Scholar] [CrossRef] [PubMed]
[28] Wang, P., Shuai, J., Leng, Z. and Ji, Y. (2023) Meta-analysis of the Application Value of Indocyanine Green Fluorescence Imaging in Guiding Sentinel Lymph Node Biopsy for Breast Cancer. Photodiagnosis and Photodynamic Therapy, 43, Article ID: 103742. [Google Scholar] [CrossRef] [PubMed]
[29] Will, O., Purkayastha, S., Chan, C., Athanasiou, T., Darzi, A.W., Gedroyc, W., et al. (2006) Diagnostic Precision of Nanoparticle-Enhanced MRI for Lymph-Node Metastases: A Meta-Analysis. The Lancet Oncology, 7, 52-60. [Google Scholar] [CrossRef] [PubMed]
[30] Vidya, R., Khosla, M., Laws, S., Harvey, J., Kaushik, M., Mullapudi, N.A., et al. (2023) Axillary Sentinel Lymph Node Identification Using Superparamagnetic Iron Oxide versus Radioisotope in Early Stage Breast Cancer: The UK Sentimag Trial (SMART Study). The Surgeon, 21, 128-134. [Google Scholar] [CrossRef] [PubMed]
[31] Man, V., Suen, D. and Kwong, A. (2023) Use of Superparamagnetic Iron Oxide (SPIO) versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial. Annals of Surgical Oncology, 30, 3237-3244. [Google Scholar] [CrossRef] [PubMed]
[32] Krischer, B., Forte, S., Niemann, T., Kubik-Huch, R.A. and Leo, C. (2018) Feasibility of Breast MRI after Sentinel Procedure for Breast Cancer with Superparamagnetic Tracers. European Journal of Surgical Oncology, 44, 74-79. [Google Scholar] [CrossRef] [PubMed]
[33] Fournier, Q., Thierry, F., Longo, M., Malbon, A., Cazzini, P., Bisson, J., et al. (2020) Contrast-Enhanced Ultrasound for Sentinel Lymph Node Mapping in the Routine Staging of Canine Mast Cell Tumours: A Feasibility Study. Veterinary and Comparative Oncology, 19, 451-462. [Google Scholar] [CrossRef] [PubMed]
[34] Niu, Z., Xiao, M., Ma, L., Qin, J., Li, W., Zhang, J., et al. (2022) The Value of Contrast-Enhanced Ultrasound Enhancement Patterns for the Diagnosis of Sentinel Lymph Node Status in Breast Cancer: Systematic Review and Meta-Analysis. Quantitative Imaging in Medicine and Surgery, 12, 936-948. [Google Scholar] [CrossRef] [PubMed]
[35] Liu, Y., Xia, M., Li, Y., Li, S., Li, H. and Li, Y. (2021) Contrast-Enhanced Ultrasound in Locating Axillary Sentinel Lymph Nodes in Patients with Breast Cancer: A Prospective Study. Ultrasound in Medicine & Biology, 47, 1475-1483. [Google Scholar] [CrossRef] [PubMed]
[36] Wang, X., Tang, L., Huang, W., Cui, Z., Hu, D., Zhong, Z., et al. (2021) The Combination of Contrast-Enhanced Ultrasonography with Blue Dye for Sentinel Lymph Node Detection in Clinically Negative Node Breast Cancer. Archives of Gynecology and Obstetrics, 304, 1551-1559. [Google Scholar] [CrossRef] [PubMed]
[37] Yang, B., Zheng, S., Huang, X., Chen, J., Liu, Z., Liu, G., et al. (2021) A Single-Center, Self-Controlled, Phase I Clinical Trial of Mitoxantrone Hydrochloride Injection for Lymph Tracing for Sentinel Lymph Node Identification of Breast Cancer. Gland Surgery, 10, 992-1001. [Google Scholar] [CrossRef] [PubMed]
[38] Jiao, D., Yang, B., Chen, J., Wang, C., Jin, L., Zhao, W., et al. (2022) Efficacy and Safety of Mitoxantrone Hydrochloride Injection for Tracing Axillary Sentinel Nodes in Breast Cancer: A Self-Controlled Clinical Trial. Frontiers in Oncology, 12, Article 914057. [Google Scholar] [CrossRef] [PubMed]
[39] Mao, Y., Liu, J., Shi, T., Chen, G. and Wang, S. (2019) A Novel Self-Assembly Nanocrystal as Lymph Node-Targeting Delivery System: Higher Activity of Lymph Node Targeting and Longer Efficacy against Lymphatic Metastasis. AAPS PharmSciTech, 20, Article No. 292. [Google Scholar] [CrossRef] [PubMed]
[40] Elzayat, I., Abdelaal, M. and Monib, S. (2023) Safety and Efficacy of Mitoxantrone Hydrochloride Injection for Identification of Axillary Sentinel Lymph Nodes in Patients with Primary Breast Cancer. World Journal of Surgery, 47, 1956-1960. [Google Scholar] [CrossRef] [PubMed]
[41] An, G. and Morris, M.E. (2010) HPLC Analysis of Mitoxantrone in Mouse Plasma and Tissues: Application in a Pharmacokinetic Study. Journal of Pharmaceutical and Biomedical Analysis, 51, 750-753. [Google Scholar] [CrossRef] [PubMed]

为你推荐